Medtech Commercial Adoption Infrastructure
The strategic infrastructure that moves medical devices
from clinical evaluation to institutional standard of care.
Request Strategy Briefing
Medtech Adoption & Commercial Scale
RankMii specializes in the narrative infrastructure that bridges the gap between successful clinical validation and institutional standard of care.
We help medical device leadership teams move from rep-driven pilots to routine procedural volume — by controlling how surgeons, VAC committees, and procurement teams evaluate, adopt, and standardize new technology.
Whether you are navigating an early commercial rollout or defending a national category, we build the strategic proof required to displace incumbent habits and secure your market position.
RankMii - The Standard for Medical Device Commercialization
We analyze the institutional logic, clinical workflows, and procurement decisions that define how new medical technology is adopted. Our work focuses exclusively on medtech leadership teams navigating the complex shift from clinical trial success to commercial scale. Whether you are an early commercial team trying to displace an incumbent habit, or a growth-stage company defending a national category, we build the strategic infrastructure required to make your technology the institutional standard.
Built for Medtech Selectively Engaged.
Exclusively Medtech
The only narrative infrastructure practice focused entirely on medical device commercialization.
Boardroom-Level Strategy
Engaging directly with CEOs, VPs of Sales, and Commercial Leadership — not handed to marketing teams.
Selective by Design
We take on a limited number of engagements per quarter to ensure category-defining outcomes for each partner.
Confidential Engagements
Our work is protected under NDA. Commercial strategy and narrative infrastructure are competitive assets — and our partners prefer them to stay that way.
Why CEOs Engage RankMii
Most medical device companies invest heavily in clinical proof but underinvest in the commercial narrative infrastructure required to convert that proof into adoption. The result is predictable: technical wins that fail to scale into routine procedural volume, sales cycles that stretch, and reps stuck performing narrative rescue instead of new account expansion.
RankMii exists to close that gap.
What RankMii Builds
🔍Narrative Friction Audit
A structured diagnostic of where your device's commercial narrative is breaking down — at the surgeon level, the VAC level, and the procurement level. We map the gap between what your team believes is being communicated and what your buyers actually encounter when they evaluate, doubt, or compare your device.
🌳Institutional Logic Mapping
Most adoption failures aren't clinical — they're structural. We map the decision logic that determines whether your device becomes the routine standard or stays a specialized alternative, and we identify the specific points where the logic currently routes around you to your incumbent competitor.
📡 Search-Driven Narrative Control
We build the digital infrastructure that ensures every search a surgeon, VAC coordinator, or procurement team conducts about your device — or your incumbent competitor — reinforces clinical confidence and economic justification, instead of doubt.
⚙️ Selective Engagement Model
We take on a limited number of medtech engagements per quarter. This is not a scaling-volume agency model. It is a strategic partnership designed to produce category-defining commercial outcomes for each partner.
🛡️ Category Defense Strategy
For early-commercial teams, the biggest risk is being categorized as a niche alternative by the dominant incumbent. We build the counter-narrative infrastructure that prevents your device from being permanently boxed into a "secondary choice" position.
🏛️ Commercial Positioning Architecture
We construct the strategic positioning assets — VAC standardization documents, reimbursement narrative pages, surgeon enablement infrastructure, and procurement-facing materials — that move your device from "specialized trial" to "institutional default.
If your medical device has achieved clinical validation but isn't yet generating routine procedural volume, the gap is rarely clinical — it's structural. And it's solvable.
Request a confidential strategy briefing to discuss how the commercial narrative infrastructure gap might be costing your team site activations, contract utilization, or commercial scale.
Request Strategy Briefing
How Engagements Work
Each engagement begins with a 2-3 week Narrative Friction Audit, designed to surface the specific commercial vulnerabilities preventing your device from achieving routine procedural adoption. From there, we build the narrative infrastructure required to close those gaps systematically.
Engagements are structured as 12-month strategic partnerships with monthly executive reviews. We meet directly with leadership — not marketing teams — to align infrastructure work with quarterly commercial milestones, board reporting cycles, and competitive positioning shifts.
Every engagement is protected under NDA. Commercial strategy and narrative infrastructure are competitive assets. Our partners prefer them to stay that way.